Table of Contents

1 Report Overview

• 1.1 Definition
• 1.2 Manufacturers and Regions Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
• 1.3 Type Overview
• 1.4 Application Overview
• 1.5 Industrial Chain
  • 1.5.1 Anti-Obesity Drugs Overall Industrial Chain
  • 1.5.2 Upstream
  • 1.5.3 Downstream
  • 1.5.4 Economic/Political Environment

2 Global Anti-Obesity Drugs Market Assesment by Types

• 2.1 Overall Market Performance
  • 2.1.1 Product Type Market Performance (Volume)
  • 2.1.2 Product Type Market Performance (Value)
• 2.2 China Anti-Obesity Drugs Market Performance
• 2.3 USA Anti-Obesity Drugs Market Performance
• 2.4 Europe Anti-Obesity Drugs Market Performance
• 2.5 Japan Anti-Obesity Drugs Market Performance
• 2.6 Korea Anti-Obesity Drugs Market Performance
• 2.7 India Anti-Obesity Drugs Market Performance
• 2.8 Southeast Asia Anti-Obesity Drugs Market Performance
• 2.9 South America Anti-Obesity Drugs Market Performance

3 Global Anti-Obesity Drugs Market Assesment by Application

• 3.1 Overall Market Performance (Volume)
• 3.2 China Anti-Obesity Drugs Market Performance (Volume)
• 3.3 USA Anti-Obesity Drugs Market Performance (Volume)
• 3.4 Europe Anti-Obesity Drugs Market Performance (Volume)
• 3.5 Japan Anti-Obesity Drugs Market Performance (Volume)
• 3.6 Korea Anti-Obesity Drugs Market Performance (Volume)
• 3.7 India Anti-Obesity Drugs Market Performance (Volume)
• 3.8 Southeast Asia Anti-Obesity Drugs Market Performance (Volume)
• 3.9 South America Anti-Obesity Drugs Market Performance (Volume)

4 Competitive Analysis

• 4.1 Pfizer
  • 4.1.1 Pfizer Profiles
  • 4.1.2 Pfizer Product Information
  • 4.1.3 Pfizer Anti-Obesity Drugs Production, Revenue, Price and Gross Margin
  • 4.1.4 Pfizer Anti-Obesity Drugs Business Performance
  • 4.1.5 SWOT Analysis
• 4.2 Merck
  • 4.2.1 Merck Profiles
  • 4.2.2 Merck Product Information
  • 4.2.3 Merck Anti-Obesity Drugs Production, Revenue, Price and Gross Margin
  • 4.2.4 Merck Anti-Obesity Drugs Business Performance
  • 4.2.5 SWOT Analysis
• 4.3 F.Hoffmann-La Roche
  • 4.3.1 F.Hoffmann-La Roche Profiles
  • 4.3.2 F.Hoffmann-La Roche Product Information
  • 4.3.3 F.Hoffmann-La Roche Anti-Obesity Drugs Production, Revenue, Price and Gross Margin
  • 4.3.4 F.Hoffmann-La Roche Anti-Obesity Drugs Business Performance
  • 4.3.5 SWOT Analysis
• 4.4 GlaxoSmithKline
  • 4.4.1 GlaxoSmithKline Profiles
  • 4.4.2 GlaxoSmithKline Product Information
  • 4.4.3 GlaxoSmithKline Anti-Obesity Drugs Production, Revenue, Price and Gross Margin
  • 4.4.4 GlaxoSmithKline Anti-Obesity Drugs Business Performance
  • 4.4.5 SWOT Analysis
• 4.5 AstraZeneca
  • 4.5.1 AstraZeneca Profiles
  • 4.5.2 AstraZeneca Product Information
  • 4.5.3 AstraZeneca Anti-Obesity Drugs Production, Revenue, Price and Gross Margin
  • 4.5.4 AstraZeneca Anti-Obesity Drugs Business Performance
  • 4.5.5 SWOT Analysis
• 4.6 Boehringer Ingelheim
  • 4.6.1 Boehringer Ingelheim Profiles
  • 4.6.2 Boehringer Ingelheim Product Information
  • 4.6.3 Boehringer Ingelheim Anti-Obesity Drugs Production, Revenue, Price and Gross Margin
  • 4.6.4 Boehringer Ingelheim Anti-Obesity Drugs Business Performance
  • 4.6.5 SWOT Analysis
• 4.7 Novo Nordisk
  • 4.7.1 Novo Nordisk Profiles
  • 4.7.2 Novo Nordisk Product Information
  • 4.7.3 Novo Nordisk Anti-Obesity Drugs Production, Revenue, Price and Gross Margin
  • 4.7.4 Novo Nordisk Anti-Obesity Drugs Business Performance
  • 4.7.5 SWOT Analysis
• 4.8 Eisai
  • 4.8.1 Eisai Profiles
  • 4.8.2 Eisai Product Information
  • 4.8.3 Eisai Anti-Obesity Drugs Production, Revenue, Price and Gross Margin
  • 4.8.4 Eisai Anti-Obesity Drugs Business Performance
  • 4.8.5 SWOT Analysis
• 4.9 Norgine
  • 4.9.1 Norgine Profiles
  • 4.9.2 Norgine Product Information
  • 4.9.3 Norgine Anti-Obesity Drugs Production, Revenue, Price and Gross Margin
  • 4.9.4 Norgine Anti-Obesity Drugs Business Performance
  • 4.9.5 SWOT Analysis
• 4.10 Arena Pharmaceuticals
  • 4.10.1 Arena Pharmaceuticals Profiles
  • 4.10.2 Arena Pharmaceuticals Product Information
  • 4.10.3 Arena Pharmaceuticals Anti-Obesity Drugs Production, Revenue, Price and Gross Margin
  • 4.10.4 Arena Pharmaceuticals Anti-Obesity Drugs Business Performance
  • 4.10.5 SWOT Analysis
• 4.11 Orexigen Therapeutics
• 4.12 Vivus
• 4.13 Alizyme
• 4.14 Rhythm Pharmaceuticals
• 4.15 Shionogi
• 4.16 Zafgan

5 Competitive Landscape

• 5.1 Global Anti-Obesity Drugs Production (K Units) and Market Share by Manufacturers (2014-2020)
• 5.2 Global Anti-Obesity Drugs Revenue (M USD) and Market Share by Manufacturers (2014-2020)
• 5.3 Global Anti-Obesity Drugs Price (USD/Unit) of Manufacturers (2014-2020)
• 5.4 Global Anti-Obesity Drugs Gross Margin of Manufacturers (2014-2020)
• 5.5 Market Concentration

6 Global Anti-Obesity Drugs Market Assessment by Regions

• 6.1 Global Anti-Obesity Drugs Production (K Units) and Market Share by Regions (2014-2020)
• 6.2 Global Anti-Obesity Drugs Revenue (M USD) and Market Share by Regions (2014-2020)
• 6.3 Global Anti-Obesity Drugs Price (USD/Unit) by Regions (2014-2020)
• 6.4 Global Anti-Obesity Drugs Gross Margin by Regions (2014-2020)

7 Anti-Obesity Drugs Regional Analysis

• 7.1 China Anti-Obesity Drugs Production, Revenue and Growth Rate (2014-2020)
• 7.2 USA Anti-Obesity Drugs Production, Revenue and Growth Rate (2014-2020)
• 7.3 Europe Anti-Obesity Drugs Production, Revenue and Growth Rate (2014-2020)
• 7.4 Japan Anti-Obesity Drugs Production, Revenue and Growth Rate (2014-2020)
• 7.5 Korea Anti-Obesity Drugs Production, Revenue and Growth Rate (2014-2020)
• 7.6 India Anti-Obesity Drugs Production, Revenue and Growth Rate (2014-2020)
• 7.7 Southeast Asia Anti-Obesity Drugs Production, Revenue and Growth Rate (2014-2020)
• 7.8 South America Anti-Obesity Drugs Production, Revenue and Growth Rate (2014-2020)

8 Global Anti-Obesity Drugs Consumption Assessment

• 8.1 Global Anti-Obesity Drugs Consumption and Market Share by Regions (2014-2020)
• 8.2 Global Anti-Obesity Drugs Consumption Value and Market Share by Regions (2014-2020)
• 8.3 Global Anti-Obesity Drugs Average Price (USD/Unit) by Regions (2014-2020)

9 Global Anti-Obesity Drugs Sales Assessment by Regions

• 9.1 Global Anti-Obesity Drugs Sales and Sales Value (2014-2020)
• 9.2 China Anti-Obesity Drugs Sales and Sales Value (2014-2020)
• 9.3 USA Anti-Obesity Drugs Sales and Sales Value (2014-2020)
• 9.4 Europe Anti-Obesity Drugs Sales and Sales Value (2014-2020)
• 9.5 Japan Anti-Obesity Drugs Sales and Sales Value (2014-2020)
• 9.6 Korea Anti-Obesity Drugs Sales and Sales Value (2014-2020)
• 9.7 India Anti-Obesity Drugs Sales and Sales Value (2014-2020)
• 9.8 Southeast Asia Anti-Obesity Drugs Sales and Sales Value (2014-2020)
• 9.9 South America Anti-Obesity Drugs Sales and Sales Value (2014-2020)

10 Technology and Cost

• 10.1 Technology
• 10.2 Cost

11 Channel Analysis

• 11.1 Market Channel
• 11.2 Distributors

12 Market Forecast 2021-2026

• 12.1 Production and Revenue Forecast 2021-2026
  • 12.1.1 Global Anti-Obesity Drugs Production and Revenue by Regions 2021-2026
  • 12.1.2 China Anti-Obesity Drugs Production, Revenue and Growth Rate 2021-2026
  • 12.1.3 USA Anti-Obesity Drugs Production, Revenue and Growth Rate 2021-2026
  • 12.1.4 Europe Anti-Obesity Drugs Production, Revenue and Growth Rate 2021-2026
  • 12.1.5 Japan Anti-Obesity Drugs Production, Revenue and Growth Rate 2021-2026
  • 12.1.6 Korea Anti-Obesity Drugs Production, Revenue and Growth Rate 2021-2026
  • 12.1.7 India Anti-Obesity Drugs Production, Revenue and Growth Rate 2021-2026
  • 12.1.8 Southeast Asia Anti-Obesity Drugs Production, Revenue and Growth Rate 2021-2026
  • 12.1.9 South America Anti-Obesity Drugs Production, Revenue and Growth Rate 2021-2026
• 12.2 Sales and Sales Value Forecast 2021-2026
  • 12.2.1 Global Anti-Obesity Drugs Consumption and Consumption Calue by Regions 2021-2026
  • 12.2.2 Global Anti-Obesity Drugs Sales and Sales Value Forecast 2021-2026
  • 12.2.3 China Anti-Obesity Drugs Sales, Sales Value and Growth Rate 2021-2026
  • 12.2.4 USA Anti-Obesity Drugs Sales and Sales Value Forecast 2021-2026
  • 12.2.5 Europe Anti-Obesity Drugs Sales and Sales Value Forecast 2021-2026
  • 12.2.6 Japan Anti-Obesity Drugs Sales and Sales Value Forecast 2021-2026
  • 12.2.7 Korea Anti-Obesity Drugs Sales and Sales Value Forecast 2021-2026
  • 12.2.8 India Anti-Obesity Drugs Sales and Sales Value Forecast 2021-2026
  • 12.2.9 Southeast Asia Anti-Obesity Drugs Sales and Sales Value Forecast 2021-2026
  • 12.2.10 South America Anti-Obesity Drugs Sales and Sales Value Forecast 2021-2026
• 12.3 Global Anti-Obesity Drugs Production and Revenue Forecast by Type 2021-2026
  • 12.3.1 Overall Market Performance
  • 12.3.2 Prescription Drugs
  • 12.3.3 OTC drugs
• 12.4 Global Anti-Obesity Drugs Sales Forecast by Application 2021-2026
  • 12.4.1 Overall Market Performance
  • 12.4.2 6-18 Callant
  • 12.4.3 18-30 Adult
  • 12.4.4 30-60Middle-Aged
  • 12.4.5 Others
• 12.5 Global Anti-Obesity Drugs Price and Gross Margin Forecast
  • 13.5.1 Global Anti-Obesity Drugs Averages Price Development Trend Forecast 2021-2026
  • 13.5.2 Global Anti-Obesity Drugs Gross Margin Development Trend Forecast 2021-2026

13 Conclusion

In this report,XYZ-research offers a comprehensive analysis of key market trends in the global Anti-Obesity Drugs market. It also includes discussion on historical trends, current market status, competitive landscape, growth opportunities and challenges which are backed by factful feedbacks. The report extensively provides quantitative analysis of the industry from 2014-2026,by Region, Type, Application. Consumption assessment by application, production by type in different regions. Furthermore, the report quantifies the market share held by the major players of the industry and provides an in-depth view of the competitive landscape. The market size in terms of revenue (USD) and production is calculated for the study period along with the details of the factors affecting the market growth (drivers and restraints). The worldwide market for Anti-Obesity Drugsmarket will reach xxx Million USD in 2020 and is expected to grow at a CAGR of xx% 2021-2026.

Geographically, global Anti-Obesity Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Pfizer
Merck
F.Hoffmann-La Roche
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Novo Nordisk
Eisai
Norgine
Arena Pharmaceuticals
Orexigen Therapeutics
Vivus
Alizyme
Rhythm Pharmaceuticals
Shionogi
Zafgan

On the basis of product, we research the production, revenue, price, market share and growth rate, primarily split into
Prescription Drugs
OTC drugs
For the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Anti-Obesity Drugs for each application, including
6-18 Callant
18-30 Adult
30-60Middle-Aged
Others
Production, consumption, revenue, market share and growth rate are the key targets for Anti-Obesity Drugs from 2014 to 2026 (forecast) in these regions
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America

If you have any special requirements, please let us know and we will offer you the report as you want.